ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 151 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,930 | -2.9% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $7,140 | -62.4% | 11,000 | 0.0% | 0.00% | -75.0% |
| Q3 2022 | $19,000 | +35.7% | 11,000 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $14,000 | +100.0% | 11,000 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $7,000 | -72.0% | 11,000 | +10.0% | 0.00% | -50.0% |
| Q4 2020 | $25,000 | 0.0% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $25,000 | -24.2% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $33,000 | +32.0% | 10,000 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $25,000 | -46.8% | 10,000 | 0.0% | 0.00% | -57.1% |
| Q4 2019 | $47,000 | +9.3% | 10,000 | 0.0% | 0.01% | -12.5% |
| Q3 2019 | $43,000 | -25.9% | 10,000 | 0.0% | 0.01% | -27.3% |
| Q2 2019 | $58,000 | +48.7% | 10,000 | 0.0% | 0.01% | +37.5% |
| Q1 2019 | $39,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
| MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
| CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
| Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
| MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
| XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
| Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
| Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
| EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |